Clinical Trials
2 trialsNCT06506955 2026-04-03
Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.
Taiho Oncology, Inc.
Phase 2/3 Enrolling by invitation
NCT06508138 2026-03-06
J21112LINKED
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Enrolling by invitation